XML 29 R18.htm IDEA: XBRL DOCUMENT v3.19.1
REVENUES (Tables)
 9 Months Ended
Sep. 30, 2018
Income Statement [Abstract]  
Statements of operations
The following table summarizes the Company’s disaggregation of revenues:
 
 
 
Nine Months Ended
September 30,
 
(U.S. dollars in thousands)
 
2018
 
 
2017
 
Pfizer
 
$
4,649
 
 
$
10,198
 
Brazil
 
$
2,573
 
 
$
6,575
 
Total revenues from selling goods
 
$
7,222
 
 
$
16,773
 
Revenues from license and R&D services
 
$
16,665